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Objective: It is unknown whether systolic blood pressure (SBP) drop is part of the 
normal aging process or due to the onset of dementia for some people. SBP drop is 
referring	to	the	decrease	in	blood	pressure	often	seen	before	death.	Thus,	the	aim	











trend was linear without any acceleration. This association between years prior to 
death	and	SBP	in	men	was	not	modified	by	age,	year	of	diagnosis,	or	diagnosis.	There	
was no such association in women.
Conclusion: SBP	was	significantly	lower	for	those	diagnosed	close	to	death	in	men,	
but not in women. This association was not modified by either age or onset of diag-
nosis.	Thus,	the	lowering	of	SBP	is	more	related	to	closeness	to	death	and	sex	than	to	
dementia	or	age.	The	downward	trend	was	linear	all	10	years	prior	to	death,	with	no	
acceleration closer to death.
K E Y W O R D S
aging,	blood	pressure,	death,	dementia,	mild	cognitive	impairment,	sex,	sex	differences,	
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1  | SIGNIFIC ANT OUTCOMES AND 
LIMITATIONS
1.	 For	 each	 year	 closer	 to	 death,	 the	 systolic	 blood	 pressure	
(SBP)	 was	 1.0	 mmHg	 lower,	 and	 the	 lowering	 of	 SBP	 was	
linear without any acceleration at the final years alive.
2. The linear lowering was significant only in men (p < .01).
3. Type of diagnosis or age was not related to the lowering of SBP.
4.	 A	 limitation	 to	 the	study	 is	 that	blood	pressure	was	only	meas-
ured	once,	at	the	time	of	diagnosis.	No	longitudinal	data	regarding	
blood pressure was available.
2  | INTRODUC TION
It is known that blood pressure drops as people approach death 
(Delgado	et	al.,	2018;	Goodwin,	2018;	Hestad	et	al.,	2020).	Delgado	
et	al.,	among	others,	have	demonstrated	in	people	over	the	age	of	
60 that blood pressure begins a downward trajectory more than 
10	years	before	death,	with	the	steepest	declines	occurring	2	years	
prior	to	death	(Delgado	et	al.,	2018).	On	the	other	hand,	studies	in-
cluding people with hypertension and vascular disorders have re-
vealed that hypertension may result in greater risk of cardiovascular 
disorders	 and	 death	 (Banegas	 et	 al.,	 2018;	 Yang	 et	 al.,	 2019),	 and	
it is well known that systolic hypertension in midlife increases the 
risk	of	vascular	dementia	(VaD)	and	dementia	due	to	Alzheimer’s	dis-
ease	(AD)	(Joas	et	al.,	2012;	Kilander	et	al.,	1998;	Kimm	et	al.,	2011;	
Kivipelto	 et	 al.,	 2001;	 Launer	 et	 al.,	 1995;	 Livingston	 et	 al.,	 2017;	
Swan	et	al.,	1998;	Swan	et	al.,	1998;	Whitmer	et	al.,	2005;	Yamada	
et	 al.,	 2003).	 Lv	et	 al.,	 found	an	a	U-	shape	curve	 in	 systolic	blood	
pressure (SBP) related to all- cause mortality in a study of old Chinese 
people,	with	 a	mean	 age	 of	 92.1	 years	 (Lv	 et	 al.,	 2018).	Minimum	
mortality	risk	was	reported	to	SBP	at	129	mmHg.	Participants	with	
an	SBP	lower	than	107	mmHg	or	higher	than	154	mmHg	had	a	sig-
nificant greater risk of death within 3 years. In another population- 
based	 study,	 including	 participants	 80	 years	 and	 older,	who	were	
on anti- hypertensive treatment it was found that SBP <135 mmHg 




<130/80	was	 associated	with	 higher	mortality	 rates.	 The	 authors	
concluded that aggressive BP treatment in frail older people requires 
further	evaluation.	In	another	population-	based	study	from	England,	
mortality increased with frailty and was greatest at SBP <110 mmHg 
(Ravindrarajah	 et	 al.,	 2017).	 The	odds	of	 having	 a	 lower	 SBP	 than	
120 were higher in the last three months before death compared 
with 5 years before in both treated and untreated (blood pressure) 
participants. The study concluded that the association of low SBP 
with	higher	mortality	may	be	due	 to	 reverse	 causation,	 for	 exam-
ple,	that	severe	sickness	before	death	may	lowering	blood	pressure.	
However,	a	study	by	Williamson	et	al.	showed	that	lowering	the	SBP	
to <120 mmHg (treatment) may led to a significant lower rates in 
all-	cause	mortality	in	people	≥75	years	of	age	compared	to	people	
without	treatment	(Williamson	et	al.,	2016).
Blood pressure is a complex process involving the central nervous 
system,	the	autonomous	system	with	barro	receptors,	hormones,	and	
other vascular parts of the body. The Renin- angiotensin- aldosterone 
hormone	 system,	which	 involve	many	parts	 of	 the	body’s	 internal	
system is of special importance. There may be many reasons for the 
decline	 in	 blood	 pressure	 before	 death,	 both	 changes	 within	 and	
outside the brain. Cancer and other diseases can as well result in 
reduced blood pressure.
The association between dementia and high SBP in midlife is re-
ported	to	diminish	prior	to,	or	close	to	the	time	when	a	diagnosis	of	
dementia	is	made	(Joas	et	al.,	2012).	As	early	as	1996,	Skoog	et	al.	
found	 that	 SBP	 declined	 after	 the	 diagnosis	 of	 both	AD	 and	VaD	
(Skoog	et	al.,	1996),	and	it	was	suggested	that	this	drop	in	SBP	could	
be a cause or consequence of the brain disease causing dementia. 
Zlokovic	et	al.,	has	proposed	a	“two-	hit	vascular	hypothesis,”	for	the	
relationship	 between	 cerebral	 vascular	 damages	 and	 Alzheimer’s	
disease	(Zlokovic,	2011).	SBP	may	first	create	cerebral	stokes,	which	
secondly	may	 result	 in	Alzheimer’s	deposits	 (Zlokovic,	2011).	As	a	




during three years of follow- up was associated with cognitive de-






an inverse association between BP and dementia risk in older per-
sons	who	use	antihypertensive	medication	(Ruitenberg	et	al.,	2001).	
The risk of dementia decreased with increasing blood pressure level 
in	that	study;	however,	the	relationship	was	confined	to	subjects	on	
antihypertensive	medication.	Nevertheless,	 it	 has	 been	 suggested	
that excessive lowering of SBP may be harmful to older patients with 
cognitive	impairment	(Mossello	et	al.,	2015).	It	is	also	suggested	that	
a decline in diastolic blood pressure occurs at an earlier age than SBP 
in	patients	with	severe	cognitive	deficits	(Hestad	et	al.,	2020).
Studies indicate that the relationship between cognitive impair-
ment and either high or low blood pressure (BP) are more clearly 
found	 in	men	 than	 in	women,	 even	 though	women	have	 the	 larg-
est	 change	 in	 blood	 pressure	 during	 aging	 (Barrett-	Connor,	 2013;	
Hestad,	Engedal,	Schirmer,	et	al.,	2020;	Joyner	et	al.,	2016).
During	 the	 aging	 process,	 an	 increasing	 number	 of	 people	 de-
velop	 dementia,	 and	 there	 seems	 to	 be	 a	 close	 connection	 be-
tween vascular events and increased risk of cognitive impairment 
and	dementia;	both	of	vascular	dementia	and	Alzheimer’s	dementia	
(Zlokovic,	2011).	It	is	also	reported	higher	mortality	rates	during	the	
progression of dementia in men compared with women. Women 
live	 longer	 than	men,	 especially	 in	 the	 severe	 stages	 of	 dementia	
(Rizzuto	et	al.,	2012).	Thus,	we	questioned	how	blood	pressure	could	
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be associated with death in patients with various degree of cogni-
tive	impairment	at	different	sex,	age,	and	anti-	hypertensive	medica-
tion.	Although,	this	is	an	observational	study	and	not	a	randomized	
controlled study it may shed some light on the relationship between 
blood pressure and related to time of death among people with cog-
nitive impairment of various degree.
Given	this	background,	we	wanted	to	examine	how	blood	pres-
sure is related to closeness of death in people who were diagnosed 
with	 dementia,	 mild	 cognitive	 impairment,	 or	 subjective	 cognitive	
decline (SCD). We were further interested to explore if sex differ-
ences	existed,	 as	our	hypothesis	was	 that	 an	association	between	
low	BP	and	time	of	death	exists	in	men,	but	not	in	women.	Likewise,	




Data were retrieved from the NorCog registry— a national research 
and quality registry for persons referred to the specialist healthcare 
service for assessment of memory impairment and possible demen-
tia. The register is based on patient consent and has existed since 
2009.	Currently,	 42	outpatient	 clinics	 collect	 data	 for	 the	 registry	
on	regular	patients	visiting	the	clinics.	Patients’	BPs	were	measured	
during	 the	NorCog	 check-	up.	 Vital	 statistics	were	 linked	 to	 study	
participants	who	were	using	 the	National	 population	 registry,	 and	
their unique personal identification number and time from BP meas-
urement to date to death were recorded.






puncture with examination of beta- amyloid and tau- protein is an 
option.	 For	 some	patients,	 Flutemetamol-	P	 (amyloid	PET)	 are	 also	
offered (https://www.helse direk torat et.no/retni ngsli njer/demens; 
(Braekhus	et	al.,	2011).
3.2 | Study population (N = 2,236)
The eligible study population comprised people with a valid BP 
measurement at the NorCog check- up at baseline and registration 
of	death	in	the	National	Death	Registry	between	2009	and	August	
2019.	Between	2009	and	2017,	6,343	patients	 aged	40	± (16 pa-
tients	 younger	 than	 40	 years	were	 removed)	were	 in	 the	 registry	
with	baseline	assessment.	Among	these,	2,505	died	before	the	end	
of	follow-	up;	BP	had	been	previously	measured	for	2,236	of	these	
patients.	 Thus,	 the	 study	 population	 consisted	 of	 2,236	 persons,	








death (from the Norwegian Death Cause Registry) are based on the 
International Classification of Diseases (ICD- 10) criteria for research 
(WHO,	 1993)	 and	made	 by	 experienced	 neurologists,	 geriatricians,	
or geriatric psychiatrists. The Winblad criteria were used for Mild 
Cognitive	impairment	(MCI)	(Winblad	et	al.,	2004),	and	patients	who	
complained about cognitive decline but showed no cognitive impair-
ment	were	given	the	diagnosis	of	SCD	(Jessen	et	al.,	2014).	Patients	
were	diagnosed	as	having	SCD	(95),	MCI	(573),	dementia	(1,401),	or	

















years prior to death as the independent variable was used in a linear 
regression.	Adjustment	variables	were	restricted	to	age,	sex,	and	year	
of diagnosis (as well as diagnosis in a supplementary analysis) as sex 
and	age	are	potential	confounders,	and	year	of	diagnosis	is	adjusted	for	
because those diagnosed later has shorter maximum follow- up time. 
Interactions between years prior to death and the variables of age and 
sex	were	investigated.	To	investigate	possible	non-	linear	relationships,	
we	applied	multivariable	regression	splines,	where	years	prior	to	death	
was modeled with cubic splines (mvrs package in Stata). To investigate 
possible	homoskedasticity	and	influence	of	outliers,	residuals	and	stu-
dentized	residuals	were	plotted	and	visually	investigated	in	kernel	den-
sity plots and in a two- way plot with the main exposure variable (years 
prior to death) along the X- axis. No severe deviation from normality 
or	homoskedasticity	was	observed.	A	sensitivity	analyses	was	re-	run	
excluding outliers (outside +-	2	studentized	residuals,	N =	98	(4.4%).
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3.5 | Ethics Statement
The	 study	 was	 approved	 by	 the	 Regional	 Ethics	 Committee	 for	
Medical	 and	 Biological	 Research	 (REK:	 2019/316),	 and	 all	 partici-
pants provided written informed consent.
4  | RESULTS
The time between BP measurement at baseline and death ranged 
from	7	 days	 to	 10.5	 years,	with	 an	 average	 of	 3.9	 years	 (SD 2.2). 
Women	 had,	 on	 average,	 significantly	 more	 years	 prior	 to	 death	
Total
Years prior to death
<1.5 1.5– 2.9 3.0– 4.9 5+
Women: n	(%) 1,159	(100) 167	(14) 247	(21) 359	(31) 386	(33)
Men: n	(%) 1,077	(100) 185	(17) 283	(26) 317	(29) 292	(27)
Mean age in years (SD)
Women 78.3	(8.5) 81.0	(8.0) 79.7	(7.4) 78.0	(8.8) 76.5	(8.6)
Men 76.6	(8.1) 78.8	(7.2) 77.9	(8.0) 76.4	(8.0) 74.3	(8.2)
Mean	SBP,	mmHg	(SD)
Women 146.4	(23.9) 147.1	(28.5) 146.8	(24.9) 145.3	(22.6) 146.9	(22.3)
Men 146.6	(22.0) 140.5	(23.0) 145.6	(22.4) 147.2	(21.3) 151.0	(20.8)
Mean	MMSE	(SD)
Women 21.5	(4.5) 21.4	(4.6) 21.0	(4.6) 21.4	(4.6) 21.9	(4.3)
Men 23.0	(4.7) 22.4	(4.9) 22.3 (5.0) 22.7	(4.6) 24.2	(4.1)
Diagnosis: n	(%)
Womena 
SCD 39	(100) 6 (15) 3	(8) 11	(28) 19	(49)
MCI 274	(100) 40	(15) 57	(21) 86	(31) 91	(33)
Dementia 758	(100) 107	(14) 167	(22) 235 (31) 249	(33)
Other 88	(100) 14	(16) 20 (23) 27	(31) 27	(31)
Menb 
SCD 56 (100) 8	(14) 12 (21) 14	(25) 22	(39)
MCI 299	(100) 56	(19) 59	(20) 89	(30) 95	(32)
Dementia 643	(100) 101 (16) 187	(29) 197	(31) 158	(25)
Other 79	(100) 20 (25) 25 (32) 17	(22) 17	(22)
a88	of	the	women	had	no	cognitive	diagnosis.
b79	of	the	men	had	no	cognitive	diagnosis.
TA B L E  1   Background table: 

















Other causes 170 13%
Total 1,291 100%
TA B L E  2   Cause of death (ICD- 10) by 
31 December 2016. Number of deaths: 
1,158
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(4.0	 years	 [SD	 2.0])	 than	did	men	 (3.7	years	 [SD 2.2]) (test for dif-
ference: p < .01). Older age was significantly associated with fewer 
years to death in both men and women (Table 1).
For	each	year	closer	to	death,	SBP	was	1.03	mmHg	lower	(95%	
confidence	 interval	 (CI)	 0.53,	 1.54),	 but	 the	 association	 between	
years prior to death and SBP was significant only for men but not 
for	women,	with	1.81	mmHg	lower	SBP	per	year	closer	to	death	in	
men	(95%	CI	1.14–	2.48).	The	corresponding	number	in	women	was	
0.29	mmHg	 (95%	CI	−0.37,	 0.94);	 Figure	1.	 Furthermore,	 a	 formal	
test of the interaction sex*years prior to death was statistically sig-
nificant (p =	.001),	suggesting	the	association	differed	according	to	
sex.	 The	more	 complex	model,	 in	which	 years	 prior	 to	 death	was	






significant interactions between the independent variables age and 
years prior to death (p =	.3),	between	years	prior	to	death	and	year	
of BP measurement (p =	 .3),	 or	between	years	prior	 to	death	and	
cognitive diagnosis (p =	.8).	In	short,	the	association	between	years	
prior to death did not differ across the levels of any of these three 
variables.
The	sensitivity	analysis,	excluding	outliers,	did	not	impact	results	
noteworthy and had no impact on the conclusions.
5  | DISCUSSION
For	each	year	closer	to	death,	SBP	was	1.03	mmHg	lower,	and	the	
lowering of SBP was linear without acceleration at the final years 
of	 life.	 The	 linear	 lowering	was	 significant	 only	 in	men,	 however	
(p < .01). We cannot find any obvious explanation for this differ-
ence,	 although	 we	 do	 have	 some	 suggestions.	 Men	 and	 women	
differ in the production of various hormones over their life spans. 
Before	menopause,	women	may	be	protected	from	both	death	and	
dementia	by	their	estrogen	production.	Joyner	et	al.,	 (2016)	have	
suggested that high levels of estrogen may be related to physiologi-
cal	control	of	BP	(Joyner	et	al.,	2016).	But	their	finding	cannot	be	
responsible for the observed sex differences of SBP in late life after 
menopause	with	reduced	estrogen,	as	we	found	a	much	higher	SBP	
in men than in women five years before death. Since we only had 
one	measurement	on	each	participant,	 it	could	be	that	situational	
factors	like	anxiety,	stress,	and	state-	based	factors	influenced	the	
blood pressure measurement. But it is no reason to believe that this 
should be different in men and women. It is more likely that the 
tendency for decline in SBP closer to death in men can be related 
to differences in cardio- vascular differences between the sexes. It 
has for a long time been known that men have a lower survival rate 
than	 females	 after	 a	 diagnosis	 of	 dementia	 (Rizzuto	 et	 al.,	 2012)	




accelerated risk of myocardial infarction in young men compared to 
young	women.	It	decreases	with	aging	(Hestad	et	al.,	2020),	but	this	
gap,	however,	never	disappears	even	if	it	becomes	smaller	(Hestad	
et	 al.,	 2020;	 Barrett-	Connor,	 2013).	 There	 is	 also	 a	 tendency	 for	
women	to	experience	cardiovascular	disease	6–	10	years	later	than	
men. Our finding related to SBP and death may reflect this delay 
in	women,	with	no	indication	of	relationship	between	SBP	decline	
and death.
Different incidences of myocardial infarction (MI) for men 
and	women,	 at	 least	 until	 age	 95,	 could	 be	 related	 to	 differences	
in sympathetic nerve activity between old men and old women 
F I G U R E  1   Time till death and blood 
pressure,	adjusted	by	age	and	year	of	
diagnosis. N =	2,236.
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(Barrett-	Connor,	2013;	Daka	et	al.,	2015).	Daka	et	al.,	 (2015)	have	
suggested that the lower incidence rates of MI in women may be 
caused by different endothelin- 1 levels. Both suggestions— the dif-
ference in sympathetic activity and in endothelin- 1 level between 
old men and women— could influence the incidence rate of MI and 
death. Our data show that a large number of persons in our study 
died of cardiovascular disease.
However,	 to	be	sure	that	state-	based	factors	rather	than	 long-	
term cerebrovascular health is the important mediator of differences 
in	SBP	related	to	death,	longitudinal	studies	are	required.
Another	 possible	 explanation	 for	 the	 sex	 difference	 found	 in	
this study may be related to differences in cell senescence path-
ways,	 which,	 in	 turn,	 may	 contribute	 to	 increased	 longevity	 in	
women and may also limit organ damage caused by hypertension 
(Colafella	&	Denton,	2018).	This	explanation	 is	unlikely,	however,	






among participants was too small for a prediction in a statistical 




cits of minor or major degree.
Our main intention with the present study was to investigate 
whether we could replicate the findings of a drop in blood pressure 
as	people	approach	death,	 and	 to	expand	on	 these	 findings	 to	 in-
vestigate whether this trend differed according to the diagnosis of 
dementia,	MCI,	or	SCI.	Further,	as	this	estimate	is	per	year,	in	men,	it	
means	that	5	years	prior	to	death	the	systolic	BP	is	9.0	mmHg	larger	
than	 immediately	 before	 death,	which	 is	 indeed	 a	 substantial	 and	
meaningful	effect	size.
Our data clearly show that there are differences regarding blood 
pressure and death in the process of aging between men and women. 
In the present study particularly related to survival after a diagnosis 
of	dementia,	MCI,	or	SCI.	For	the	clinician,	it	can	be	difficult	to	know	
if the low blood pressure is related to a cognitive disorder or if it 
could	be	an	indication	of	general	deteriorating	of	health,	especially	in	
men.	Underlying	poor	cardio-	vascular	health	in	people	with	demen-
tia should be screened for and treated if indicated.
The strength of this study is the large number of patients in our 
sample,	 although	 it	 does	 have	 some	 obvious	 limitations,	 including	
lack of a control group from a healthy population. The study was 
cross-	sectional,	 in	which	 patients’	 BPs	were	 studied	 at	 one	 point,	
with	no	longitudinal	follow-	up	data	of	SBP.	Although	health	person-






Systolic blood pressure decreases significantly from time of diagno-
sis	of	cognitive	decline	to	death	in	men,	but	not	in	women.	The	SBP	
drop was not modified by age or by diagnosis of cognitive deficits.
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